• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估每日阿伐那非对改善埃及勃起功能障碍男性内皮功能的疗效。

Evaluation of daily avanafil efficacy in improving the endothelial function in Egyptian males with erectile dysfunction.

机构信息

Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.

Department of Medical Physiology, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.

出版信息

Andrologia. 2021 Feb;53(1):e13833. doi: 10.1111/and.13833. Epub 2020 Oct 28.

DOI:10.1111/and.13833
PMID:33112433
Abstract

Avanafil is a highly selective and potent oral phosphodiesterase type 5 inhibitor. However, its impact on the soluble markers of endothelial function has not been investigated yet. This study was conducted to assess the effect of daily avanafil on the endothelial markers' serum level and erectile function in patients with erectile dysfunction. In this work, we randomly divided 140 males with erectile dysfunction and other diseases commonly associated with endothelial dysfunction like diabetes mellitus, hypertension and dyslipidaemia into two equal groups: treatment group, treated with 50mg daily oral avanafil, and control group, treated with placebo. The International Index of Erectile Function-5 score and the serum levels of nitric oxide, cyclic guanosine monophosphate and endothelin-1 as markers of endothelial function were measured at baseline and after four weeks of treatment in both groups. At the end of treatment period, those randomised to avanafil achieved statistically significant improvement in erectile function, nitric oxide, cyclic guanosine monophosphate and endothelin-1 levels from baseline versus placebo regardless the type and duration of associated comorbidity as well as the duration and severity of erectile dysfunction. These results permitted us to suggest that daily avanafil can improve the impaired endothelial function associated with the erectile dysfunction.

摘要

阿伐那非是一种高度选择性和有效的口服磷酸二酯酶 5 抑制剂。然而,其对内皮功能可溶性标志物的影响尚未被研究过。本研究旨在评估每日服用阿伐那非对勃起功能障碍患者内皮标志物血清水平和勃起功能的影响。在这项工作中,我们将 140 名患有勃起功能障碍和其他常见与内皮功能障碍相关的疾病(如糖尿病、高血压和血脂异常)的男性随机分为两组:治疗组,每天口服 50mg 阿伐那非治疗;对照组,给予安慰剂治疗。在两组中,均在基线和治疗 4 周后测量国际勃起功能指数-5 评分和血清一氧化氮、环磷酸鸟苷和内皮素-1 水平作为内皮功能的标志物。在治疗期末,与安慰剂相比,随机分配到阿伐那非组的患者在勃起功能、一氧化氮、环磷酸鸟苷和内皮素-1 水平方面均有统计学显著改善,无论合并症的类型和持续时间以及勃起功能障碍的持续时间和严重程度如何。这些结果表明,每日服用阿伐那非可以改善与勃起功能障碍相关的受损内皮功能。

相似文献

1
Evaluation of daily avanafil efficacy in improving the endothelial function in Egyptian males with erectile dysfunction.评估每日阿伐那非对改善埃及勃起功能障碍男性内皮功能的疗效。
Andrologia. 2021 Feb;53(1):e13833. doi: 10.1111/and.13833. Epub 2020 Oct 28.
2
Avanafil for treatment of erectile dysfunction: review of its potential.阿伐那非用于治疗勃起功能障碍:其潜力综述
Vasc Health Risk Manag. 2012;8:517-23. doi: 10.2147/VHRM.S26712. Epub 2012 Aug 29.
3
A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Therapeutic Confirmatory Study to Evaluate the Safety and Efficacy of Avanafil in Korean Patients with Erectile Dysfunction.一项随机、安慰剂对照、双盲、多中心治疗性确证研究,以评估阿伐那非在韩国勃起功能障碍患者中的安全性和有效性。
J Korean Med Sci. 2017 Jun;32(6):1016-1023. doi: 10.3346/jkms.2017.32.6.1016.
4
Avanafil for erectile dysfunction.阿伐那非治疗勃起功能障碍。
Ann Pharmacother. 2013 Oct;47(10):1312-20. doi: 10.1177/1060028013501989. Epub 2013 Sep 27.
5
Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitus.阿伐那非治疗糖尿病男性勃起功能障碍的多中心、随机、双盲研究。
Mayo Clin Proc. 2012 Sep;87(9):843-52. doi: 10.1016/j.mayocp.2012.06.016. Epub 2012 Aug 1.
6
Efficacy and safety of avanafil for treating erectile dysfunction: results of a multicentre, randomized, double-blind, placebo-controlled trial.阿伐那非治疗勃起功能障碍的疗效和安全性:一项多中心、随机、双盲、安慰剂对照试验的结果。
BJU Int. 2012 Dec;110(11):1801-6. doi: 10.1111/j.1464-410X.2012.11095.x. Epub 2012 Mar 27.
7
Avanafil for the treatment of erectile dysfunction. An updated review.阿伐那非用于治疗勃起功能障碍。一项最新综述。
Arch Esp Urol. 2014 Dec;67(10):839-47.
8
A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction.一项评估阿伐那非治疗勃起功能障碍安全性和有效性的随机、双盲、安慰剂对照研究。
J Sex Med. 2012 Apr;9(4):1122-33. doi: 10.1111/j.1743-6109.2011.02629.x. Epub 2012 Jan 16.
9
Evaluation of the Effect on Sexual Performance of a Nutraceutical Combination Containing Alpha Lipoic Acid, L. and , Compared to Placebo, Avanafil or a Combination of Nutraceutical Plus Avanafil in Males With Type 2 Diabetes Mellitus With Erectile Dysfunction.评价含有 α-硫辛酸、育亨宾和 的营养组合对 2 型糖尿病伴勃起功能障碍男性性功能的影响,与安慰剂、阿伐那非或营养组合加阿伐那非相比。
Front Endocrinol (Lausanne). 2022 Apr 7;13:847240. doi: 10.3389/fendo.2022.847240. eCollection 2022.
10
Selectivity of avanafil, a PDE5 inhibitor for the treatment of erectile dysfunction: implications for clinical safety and improved tolerability.阿伐那非(一种用于治疗勃起功能障碍的 PDE5 抑制剂)的选择性:对临床安全性和改善耐受性的影响。
J Sex Med. 2012 Aug;9(8):2122-9. doi: 10.1111/j.1743-6109.2012.02822.x. Epub 2012 Jul 3.

引用本文的文献

1
The Efficacy and Safety of Avanafil During a Treatment of Male Erectile Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.阿伐那非治疗男性勃起功能障碍的疗效与安全性:随机对照试验的系统评价与荟萃分析
Ther Clin Risk Manag. 2023 Jul 18;19:629-644. doi: 10.2147/TCRM.S419408. eCollection 2023.
2
Understanding human aging and the fundamental cell signaling link in age-related diseases: the middle-aging hypovascularity hypoxia hypothesis.理解人类衰老以及与年龄相关疾病中的基本细胞信号传导联系:中年血管减少性缺氧假说。
Front Aging. 2023 Jun 13;4:1196648. doi: 10.3389/fragi.2023.1196648. eCollection 2023.
3
Bioinformatic Exploration of Hub Genes and Potential Therapeutic Drugs for Endothelial Dysfunction in Hypoxic Pulmonary Hypertension.
缺氧性肺动脉高压内皮功能障碍的枢纽基因与潜在治疗药物的生物信息学研究
Comput Math Methods Med. 2022 Nov 28;2022:3677532. doi: 10.1155/2022/3677532. eCollection 2022.
4
Identification, synthesis and characterization of avanafil process impurities and determination by UPLC.阿伐那非工艺杂质的鉴定、合成与表征及超高效液相色谱法测定
RSC Adv. 2022 Mar 24;12(15):9256-9262. doi: 10.1039/d2ra01224c. eCollection 2022 Mar 21.